Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03110822
Brief Title: A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

First Submitted : February 27, 2017
First Submitted that Met QC Criteria : April 6, 2017
First Posted : April 12, 2017

Last Update Submitted that Met QC Criteria : April 30, 2019
Last Update Posted : May 2, 2019